# BHST (Bioharvest Sciences Inc.) - SEC EDGAR Financial Statements

> Bioharvest Sciences Inc. reported $34.51M in revenue and a net loss of $11.13M for the fiscal year ended December 31, 2025 (up 37.0% year over year), with a 59.3% gross margin and a -16.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/BHST
- Markdown: https://convexityos.com/fundamentals/BHST.md
- SEC CIK: 0001723464
- Reporting currency: USD
- Latest filing period: December 31, 2025
- Last synced: Nov 21, 2026, 05:01 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001723464&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $34.51M | +37.0% YoY |
| Operating Income | FY 2025 | -$5.58M | -16.2% margin |
| Net Income | FY 2025 | -$11.13M | -32.3% net margin |
| Diluted EPS | FY 2025 | -- | Split-adjusted |
| Free Cash Flow | FY 2025 | -$9.58M | -27.8% FCF margin |
| Cash & ST Investments | Dec 31, 2025 | $23.02M | Total debt: $10.28M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $34.51M | $25.19M | $12.67M |
| Cost of Revenue | $14.03M | $11.25M | $7.04M |
| **Gross Profit** | $20.48M | $13.94M | $5.63M |
| Research & Development | $5.31M | $4.80M | $3.37M |
| Selling, General & Admin | $20.74M | $16.13M | $12.23M |
| Total Operating Expenses | $26.05M | $20.93M | $15.60M |
| **Operating Income** | -$5.58M | -$6.99M | -$9.97M |
| **EBITDA** | -$3.95M | -$5.74M | -$9.13M |
| Income Before Tax | -$11.06M | -$12.90M | -$12.56M |
| Income Tax Expense | -$76K | -$8.0K | $0 |
| **Net Income** | -$11.13M | -$12.91M | -$12.56M |
| Basic EPS | -$0.60 | -$0.80 | -$0.93 |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $23.02M | $2.39M | $5.36M |
| **Cash & Short-Term Investments** | $23.02M | $2.39M | $5.36M |
| Accounts Receivable, Net | $1.98M | $1.12M | $808K |
| Inventory | $4.56M | $3.65M | $2.47M |
| **Total Current Assets** | $30.50M | $7.86M | $9.05M |
| Property, Plant & Equipment, Net | $8.33M | $7.75M | $3.93M |
| **Total Non-Current Assets** | $17.16M | $17.14M | $5.95M |
| **Total Assets** | $47.66M | $25.00M | $15.00M |
| Accounts Payable | $2.63M | $3.52M | $1.78M |
| Short-Term Debt | $149K | $3.90M | $0 |
| Other Current Liabilities | $452K | $1.14M | $0 |
| **Total Current Liabilities** | $7.68M | $14.26M | $26.47M |
| Other Non-Current Liabilities | $1.98M | $272K | $1.96M |
| **Total Non-Current Liabilities** | $14.53M | $9.41M | $3.39M |
| **Total Liabilities** | $22.22M | $23.67M | $29.86M |
| **Total Debt (incl. Leases)** | $10.28M | $13.05M | $1.43M |
| Retained Earnings | -$107.6M | -$96.42M | -$83.50M |
| **Total Stockholders' Equity** | $25.45M | $1.33M | -$14.85M |
| Total Equity | $25.45M | $1.33M | -$14.85M |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $23.02M | $2.39M | $5.36M |
| **Cash & Short-Term Investments** | $23.02M | $2.39M | $5.36M |
| Accounts Receivable, Net | $1.98M | $1.12M | $808K |
| Inventory | $4.56M | $3.65M | $2.47M |
| **Total Current Assets** | $30.50M | $7.86M | $9.05M |
| Property, Plant & Equipment, Net | $8.33M | $7.75M | $3.93M |
| **Total Non-Current Assets** | $17.16M | $17.14M | $5.95M |
| **Total Assets** | $47.66M | $25.00M | $15.00M |
| Accounts Payable | $2.63M | $3.52M | $1.78M |
| Short-Term Debt | $149K | $3.90M | $0 |
| Other Current Liabilities | $452K | $1.14M | $0 |
| **Total Current Liabilities** | $7.68M | $14.26M | $26.47M |
| Other Non-Current Liabilities | $1.98M | $272K | $1.96M |
| **Total Non-Current Liabilities** | $14.53M | $9.41M | $3.39M |
| **Total Liabilities** | $22.22M | $23.67M | $29.86M |
| **Total Debt (incl. Leases)** | $10.28M | $13.05M | $1.43M |
| Retained Earnings | -$107.6M | -$96.42M | -$83.50M |
| **Total Stockholders' Equity** | $25.45M | $1.33M | -$14.85M |
| Total Equity | $25.45M | $1.33M | -$14.85M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$11.13M | -$12.91M | -$12.56M |
| Depreciation & Amortization | $1.62M | $1.25M | $840K |
| Stock-Based Compensation | -- | $601K | $563K |
| Change in Receivables | -$865K | -$308K | -$262K |
| Change in Inventory | -$904K | -$1.19M | -$1.09M |
| **Operating Cash Flow** | -$7.23M | -$6.68M | -$8.52M |
| Capital Expenditure | -$2.35M | -$2.83M | -$1.47M |
| **Free Cash Flow** | -$9.58M | -$9.52M | -$10.00M |
| **Investing Cash Flow** | -$2.37M | -$3.03M | -$1.47M |
| Common Stock Issued | $18.26M | $0 | $0 |
| **Financing Cash Flow** | $30.19M | $6.78M | $13.56M |
| **Net Change in Cash** | $20.60M | -$2.93M | $3.56M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Gross Margin** | 59.3% | 55.4% | 44.5% |
| **Operating Margin** | -16.2% | -27.7% | -78.6% |
| **Net Profit Margin** | -32.3% | -51.3% | -99.1% |
| Return on Equity (ROE) | -43.8% | -970.9% | -- |
| Return on Assets (ROA) | -23.4% | -51.6% | -83.7% |
| Current Ratio | 3.97x | 0.55x | 0.34x |
| Quick Ratio | 3.38x | 0.29x | 0.25x |
| Debt to Equity | 0.40x | 9.81x | -- |
| **Revenue Growth (YoY)** | +37.0% | +98.8% | -- |
| Gross Profit Growth (YoY) | +46.9% | +147.5% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
